Ab Artea Bankas · OMXVSE:ROE1L
Ab Artea Bankas — BOD Lenses — Debt Investor Presentation (August 2026)
33 slides from Ab Artea Bankas's debt investor presentation, August 2026
Slide 1: Investor Presentation
INVESTOR PRESENTATION August 2026
Slide 2: Table of Contents
Table of Contents Executive Summary 4 Company Overview 5 Financial Overview 20 Bond Offering 22 Contacts 29 Vilnius · August 2026
Slide 3: Important notice
Important notice This Investor Presentation (the “Presentation”) is neither considered as a prospectus as defined in Regulation No. 2017/1129, nor information document as defined under the Law on Securities of the Republic of Lithuania. Moreover, this Presentation is not approved by any financial su
Slide 4: Executive Summary
EXECUTIVE SUMMARY BOD Lenses is an independent B2B manufacturer of prescription (Rx) Summary of the key Terms of the Bonds ophthalmic lenses based in Vilnius, Lithuania, and forms part of BOD GROUP. The BOD GROUP’s engineering and high-technology Issue size Up to EUR 4 000 000 manufacturing experien
Slide 5: Company Overview
;e ) Bod Lenses COMPANY OVERVIEW life - see
Slide 6: Company at a Glance
COMPANY AT A GLANCE • B2B manufacturer of prescription (Rx) ophthalmic lenses — part of Global BOD Group, based in Vilnius, with 20+ years of industry experience. • Lens business launched in 2014 on the group’s thin-film coating heritage; fully automated digital production. • FY2025 revenue €13.21M
Slide 7: Company Vision
COMPANY VISION By 2029, BOD Lenses is a manufacturer of individualized RX lenses and a leader in implementing innovations, providing optical businesses worldwide with top-quality products and vision solutions. 7
Slide 8: Products and Technologies
PRODUCTS AND TECHNOLOGIES LENS TYPES MATERIALS COATINGS TECHNOLOGIES TINTING • SINGLE VISION LENSES • TRANSITIONS • ULTRASLIK • COLOR SIGHT • NUPOLAR • TINTED UNIVERSE • PROGRESSIVE LENSES • NEOCHROMES • SERICUM UV • DIGITAL RAY-PATH 2 • TINTING • BIFOCAL LENSES • SOLIS II • CLARUS II • CAMBER • NAN
Slide 9: Group History
GROUP HISTORY Year Milestone Founded as Baltic Optical Disc — the first industrial CD plant in Eastern Europe (Vilnius, later 1998 Tallinn); core competence in ultra-thin coatings. 2009 SoliTek founded (solar cells & modules), built on the same coating-technology base. BOD Lenses business and factor
Slide 10: BOD Lenses History
BOD LENSES HISTORY CD/DVD Full lab automation In-house lens 1st Sustainability L.I.G.H.T. WING business is born and robotization quality testing lab Report The greenest industrial 2013 2021 2023 2022 1998 building in Europe 2024 2023 2021 2015 2009 Industry 4.0 digital Bod Frames Solar energy Optica
Slide 11: Investment Highlights
INVESTMENT HIGHLIGHTS ✓ FY2025 revenue €13.21M (+0.2%); Net profit (~€0.38M) ✓ 2026 Jan–Jun revenue €7.74M (+9%), 37% gross margin, ~€0.9M EBITDA ✓ ~80% exported to 31 countries; 2–3 new markets per year ✓ Defensive ~€4.7bn European lens market growing ~4.6% a year ✓ Independent B2B model + German t
Slide 12: Business & Operations
BUSINESS & OPERATIONS • B2B only — sells to independent optical stores and national distributors, with no retail arm, so it never competes with its own customers. • White-label enablement: branded packaging, lens passport cards, localized catalogues, IT integration and the opticalo.eu online orderin
Slide 13: Products/Markets and Growth Strategy
PRODUCTS/MARKETS AND GROWTH STRATEGY • Broad Rx portfolio — single vision, bifocal, digital / • BOD Lenses’ expansion strategy focuses on geographic anti-fatigue and free-form progressive lenses, diversification and export growth, strengthening its position in covering both everyday and premium visi
Slide 14: Planned Investments and Expansion Plans
PLANNED INVESTMENTS AND EXPANSION PLANS The planned investments of 1.9 M Eur are primarily aimed at eliminating the current production bottleneck in the lens generating department and increasing its capacity from approximately 4,000 to 5,500 lenses per day. In parallel, BOD Lenses plans to further i
Slide 15: Sustainability at the Core
SUSTAINABILITY AT THE CORE Bod Lenses ESG goals are aligned with the United Nations Sustainable Development Goals (SDGs), focusing on the priority sustainability areas below. ENVIRONMENTAL SOCIAL GOVERNANCE 15
Slide 16: Green Products Made With Green Energy Only; Fully Energy-Autonomous Building
Green Products Made With Green Fully Energy-Autonomous Energy Only Building • Solar panels manufactured using 100 % green power • 850 kW solar power plant: on roof & façade • 250 kW solar power plant on the roof • 80 geothermal boreholes (15,75 km of geothermal energy) • 105 geothermal boreholes (10
Slide 17: Technology Development Partners
TECHNOLOGY DEVELOPMENT PARTNERS 17
Slide 18: BOD Lenses Structure
BOD LENSES STRUCTURE SHAREHOLDERS UBO Vidmantas Janulevičius 80.67% Vladas Sakalauskas 19.33% Vytautas Tuminas BOD Lenses AS Global BOD Group SIA 15% 16.25% 68.75% Vytautas Tuminas, CEO of BOD Lenses Head of Technology and Commercial Manager Production Manager Quality Povilas Steponavičius Evaldas P
Slide 19: The Team
THE TEAM Vytautas Tuminas Evaldas Pažemeckas Lukas Jočionis Povilas Steponavičius CEO Production Manager Head of Technology and Chief Commercial Officer Vytautas leads BOD lenses for Evaldas has acted as a Quality Povilas has been in this role more than 11 years, with 13 production manager for Lukas
Slide 20: Financial Overview
;e ) Bod Lenses FINANCIAL oveevin® life - see
Slide 21: Financial Highlights
FINANCIAL HIGHLIGHTS 2026 H1 €m 2024 2025 (Unaudited) Revenue 13.2 13.2 7.7 Revenue growth — +0.2% +9% Gross profit 5.1 4.9 2.8 Gross margin 38.5% 37.2% 36.4% EBITDA 1.7 1.4 0.9 EBITDA margin 12.7% 10.7% 11.7% Net profit 0.5 0.4 0.5 Net margin 4.0% 3.7% 6.5% Total Assets 7.4 10.9 8.5 Total Liabiliti
Slide 22: Bond Offering
° rN D Bod Lenses BOND OFFERING life - see it well.
Slide 23: Bond Terms & Structure
BOND TERMS & STRUCTURE Issuer: UAB BOD Lenses ISIN: LT0000138653 Status of the Bonds: Secured by Surety Specified Currency: Euro (EUR) Aggregate Nominal Amount: EUR 4,000,000 Issue Price: EUR 1,000 Specified Denominations: EUR 1,000 Issue Date: 2 September 2026 Maturity Date: 2 October 2028 Subscrip
Slide 24: Subscription / Payment / Allocation / Settlement (1/3)
SUBSCRIPTION/ PAYMENT /ALLOCATION/SETTLEMENT (1/3) Subscription Procedure for Existing Boldholders By filing a respective corporate event notification to the Nasdaq CSD, the Issuer will offer to all Existing Bondholders to exchange the Existing Bonds for new Bonds to be issued under this Information
Slide 25: Subscription / Payment / Allocation / Settlement (2/3)
SUBSCRIPTION/ PAYMENT /ALLOCATION/SETTLEMENT (2/3) Setting Interest Rate (Coupon) The Investors acknowledge that the Interest Rate (coupon) of the Bonds shall be determined upon the discretion of the Issuer within the range indicated in the Final Terms, taking into consideration, among other factors
Slide 26: Subscription / Payment / Allocation / Settlement (3/3)
SUBSCRIPTION/ PAYMENT /ALLOCATION/SETTLEMENT (3/3) Payment for the Bonds By submitting a Subscription Order each Investor authorises and instructs the Exchange Member through which the Subscription Order is submitted to immediately block the whole subscription amount on the Investor’s cash account c
Slide 27: Risk Factors I
RISK FACTORS I Issuer specific risk factors Market and Customer Risk The majority of the Issuer’s revenue is generated in export markets. Notwithstanding, that the Company is diversifying sales across different geographic markets, expanding operations in Germany, the Netherlands, Switzerland, the Un
Slide 28: Risk Factors II
RISK FACTORS II Risks Related to Growth and Investment Implementation The Issuer’s strategy calls for significant geographic expansion, the development of new product categories, and improvements in manufacturing efficiency. Expansion projects may require additional investments and managerial resour
Slide 29: Risk Factors III
RISK FACTORS III Operational and safety risks Issuer’s business activities involve risks, such as accidents, equipment defects, malfunctions and failures and natural disasters. These risks expose the Issuer to potential liability for pollution and other environmental damages, personal injury, loss o
Slide 30: Risk Factors IV
RISK FACTORS IV Interest rate and inflation risk If interest rates in general or particularly with regard to obligations of corporate debtors or corporate debtors with activities in the industries sector for durations equal to the remaining term of the Bonds increase, the market value of the Bonds m
Slide 31: Risk Factors V
RISK FACTORS V Early redemption risk According to the General Terms and Conditions of the Bonds, the Bonds may be redeemed prematurely on the initiative of the Issuer 6 months after the Issue Date. The Issuer may choose to redeem the Bonds, subject to certain regulatory conditions and approvals, at
Slide 32: Risk Factors VI
RISK FACTORS VI Refinancing risk The Issuer may be required to refinance certain or all of its outstanding debt, including the Bonds. The Issuer's ability to successfully refinance its debt is dependent on the conditions of the debt capital markets and its financial condition at such time. Even if t
Slide 33: Contacts
CONTACTS UAB BOD Lenses Mokslininkų g. 6A, Vilnius, Lithuania bodlenses.com · +370 5 232 23 38 info@bodlenses.com +370 5210 3354 broker@artea.lt 33
BOD Lenses — Debt Investor Presentation (August 2026) on 6ix